|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4980286A
(en)
|
1985-07-05 |
1990-12-25 |
Whitehead Institute For Biomedical Research |
In vivo introduction and expression of foreign genetic material in epithelial cells
|
|
US4737323A
(en)
|
1986-02-13 |
1988-04-12 |
Liposome Technology, Inc. |
Liposome extrusion method
|
|
ATE141646T1
(de)
|
1986-04-09 |
1996-09-15 |
Genzyme Corp |
Genetisch transformierte tiere, die ein gewünschtes protein in milch absondern
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US4873316A
(en)
|
1987-06-23 |
1989-10-10 |
Biogen, Inc. |
Isolation of exogenous recombinant proteins from the milk of transgenic mammals
|
|
US4992417A
(en)
|
1987-07-17 |
1991-02-12 |
Mount Sinai School Of Medicine |
Superactive human insulin analogues
|
|
US5082670A
(en)
|
1988-12-15 |
1992-01-21 |
The Regents Of The University Of California |
Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5328470A
(en)
|
1989-03-31 |
1994-07-12 |
The Regents Of The University Of Michigan |
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
|
|
US5427940A
(en)
|
1991-06-03 |
1995-06-27 |
Board Of Regents, The University Of Texas System |
Engineered cells producing insulin in response to glucose
|
|
PT671923E
(pt)
|
1992-10-09 |
2001-10-30 |
Advanced Tissue Sciences Inc |
Celulas de reserva do figado
|
|
US5523226A
(en)
|
1993-05-14 |
1996-06-04 |
Biotechnology Research And Development Corp. |
Transgenic swine compositions and methods
|
|
US5424286A
(en)
|
1993-05-24 |
1995-06-13 |
Eng; John |
Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
|
|
EP0714438B1
(en)
|
1993-08-16 |
2007-09-19 |
RESEARCH DEVELOPMENT FOUNDATION (a Nevada corporation) |
A novel homeobox factor which stimulates insulin expression in pancreatic islet cells
|
|
US5858973A
(en)
|
1994-02-23 |
1999-01-12 |
The General Hospital Corporation |
Transcription factor and uses therefor
|
|
IL114193A
(en)
|
1994-06-20 |
2000-02-29 |
Teva Pharma |
Ophthalmic pharmaceutical compositions based on sodium alginate
|
|
US5849989A
(en)
|
1994-10-07 |
1998-12-15 |
Ontogeny, Inc. |
Insulin promoter factor, and uses related thereto
|
|
ATE321880T1
(de)
|
1995-11-30 |
2006-04-15 |
Res Dev Foundation |
Nachweisverfahren für verbindungen, welche die somatostatin- und insulinproduktion stimulieren
|
|
IL118376A0
(en)
|
1996-05-22 |
1996-09-12 |
Univ Ben Gurion |
Polysaccharide sponges for cell culture and transplantation
|
|
EP0929573A1
(en)
|
1996-06-24 |
1999-07-21 |
Vivorx Pharmaceuticals, Inc. |
Methods for the isolation and proliferation of insulin-secreting cells
|
|
EP0996736A1
(en)
|
1997-08-11 |
2000-05-03 |
Chiron Corporation |
Methods for genetically modifying t cells
|
|
CA2221195A1
(en)
|
1997-11-14 |
1999-05-14 |
Chantal E. Holy |
Biodegradable polymer matrix
|
|
US6143293A
(en)
|
1998-03-26 |
2000-11-07 |
Carnegie Mellon |
Assembled scaffolds for three dimensional cell culturing and tissue generation
|
|
IL124957A0
(en)
|
1998-06-16 |
1999-01-26 |
Univ Ben Gurion |
Active ingredient delivery systems and devices based on porous matrices
|
|
US6242666B1
(en)
|
1998-12-16 |
2001-06-05 |
The Scripps Research Institute |
Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
|
|
US6774120B1
(en)
|
1999-06-01 |
2004-08-10 |
Sarah Ferber |
Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
|
|
US8778899B2
(en)
|
1999-06-01 |
2014-07-15 |
Sarah Ferber |
Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
|
|
US6716824B1
(en)
|
1999-10-22 |
2004-04-06 |
F. Charles Brunicardi |
Treatment of pancreatic adenocarcinoma by cytotoxic gene therapy
|
|
US6759039B2
(en)
|
2000-06-30 |
2004-07-06 |
Amcyte, Inc. |
Culturing pancreatic stem cells having a specified, intermediate stage of development
|
|
US7214371B1
(en)
|
2000-09-01 |
2007-05-08 |
Ben-Gurion University Of The Negev Research & Development Authority |
Tissue engineered biografts for repair of damaged myocardium
|
|
US7524492B2
(en)
|
2001-08-31 |
2009-04-28 |
Joslin Diabetes Center, Inc. |
Insulin related transcription factor and uses thereof
|
|
WO2003033697A1
(en)
|
2001-10-18 |
2003-04-24 |
Ixion Biotechnology, Inc. |
Conversion of liver stem and progenitor cells to pancreatic functional cells
|
|
US7722894B2
(en)
|
2001-10-22 |
2010-05-25 |
Massachusetts Institute Of Technology |
Biodegradable polymer
|
|
CN101240262A
(zh)
|
2001-12-07 |
2008-08-13 |
杰龙公司 |
源自人胚胎干细胞的胰岛细胞
|
|
WO2003072728A2
(en)
*
|
2002-02-22 |
2003-09-04 |
University Of Florida |
Cellular trans-differentiation
|
|
GB0206357D0
(en)
|
2002-03-18 |
2002-05-01 |
Univ Bath |
Cells
|
|
JP4136434B2
(ja)
|
2002-04-17 |
2008-08-20 |
進 清野 |
インスリン産生細胞の誘導
|
|
US20060122104A1
(en)
|
2002-05-28 |
2006-06-08 |
Presnell Sharon C |
Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells
|
|
MXPA05011896A
(es)
|
2003-05-05 |
2006-05-25 |
Univ Ben Gurion |
Preparaciones polimericas reticuladas inyectables y sus usos.
|
|
WO2004098646A1
(en)
|
2003-05-12 |
2004-11-18 |
Sarah Ferber |
Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
|
|
EP1649000A4
(en)
|
2003-06-30 |
2008-04-30 |
Lifescan Inc |
EXPOSURE OF PANCREATIC CELLS TO POROUS MATRICES
|
|
US20060205072A1
(en)
|
2003-08-27 |
2006-09-14 |
Nobuko Uchida |
Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
|
|
EP1697494B1
(en)
|
2003-12-09 |
2012-02-22 |
Ben-Gurion University Of The Negev Research And Development Authority |
Pulse-medium perfusion bioreactor with improved mass transport for multiple 3-d cell constructs
|
|
EP1784481A1
(en)
|
2004-08-25 |
2007-05-16 |
Technion Research And Development Foundation, Ltd. |
Methods of generating embryoid bodies using three dimensional scaffolds
|
|
WO2006092799A1
(en)
|
2005-03-02 |
2006-09-08 |
Polyrizon Ltd. |
Method for removal of toxins from mucosal membranes
|
|
WO2006095342A2
(en)
|
2005-03-07 |
2006-09-14 |
Technion Research & Development Foundation Ltd. |
Natural tissue-derived decellularized matrix and methods of generating and using same
|
|
US7517856B2
(en)
|
2005-10-11 |
2009-04-14 |
Ben-Gurion University Of The Negev Research And Development Authority |
Bioconjugates comprising sulfated polysaccharides and their uses
|
|
EP2054079A4
(en)
|
2006-07-19 |
2009-12-23 |
Univ Florida |
COMPOSITIONS FOR CELL REPROGRAMMING AND USES THEREOF
|
|
WO2008075339A2
(en)
|
2006-12-18 |
2008-06-26 |
Ben Gurion University Of The Negev |
Scaffolding for tissue regeneration or repair
|
|
EP2176400B1
(en)
|
2007-07-11 |
2015-10-14 |
Technion Research & Development Foundation Ltd. |
Encapsulated mesenchymal stem cells and uses thereof
|
|
IL187707A0
(en)
|
2007-11-27 |
2008-11-03 |
Univ Ben Gurion |
Alginate scaffold in hepatectomy
|
|
WO2009126927A2
(en)
*
|
2008-04-11 |
2009-10-15 |
Joslin Diabetes Center, Inc. |
Methods of generating insulin-producing cells
|
|
WO2010022395A2
(en)
*
|
2008-08-22 |
2010-02-25 |
President And Fellows Of Harvard College |
Methods of reprogramming cells
|
|
WO2011016423A1
(ja)
|
2009-08-02 |
2011-02-10 |
学校法人 東京女子医科大学 |
膵島細胞シート、製造方法及びその利用方法
|
|
DK2494039T3
(da)
*
|
2009-10-31 |
2019-08-19 |
Genesis Tech Limited |
Fremgangsmåder til reprogrammering af celler og anvendelser deraf
|
|
JP2011223993A
(ja)
|
2010-03-30 |
2011-11-10 |
Kumamoto Univ |
幹細胞の分化誘導方法
|
|
EP3399026B1
(en)
|
2010-06-14 |
2024-06-26 |
The Scripps Research Institute |
Reprogramming of cells to a new fate
|
|
WO2013021389A2
(en)
|
2011-08-09 |
2013-02-14 |
Yeda Research And Development Co.Ltd. |
Downregulation of mir-7 for promotion of beta cell differentiation and insulin production
|
|
EP2816964B1
(en)
|
2012-02-21 |
2023-12-27 |
Ben-Gurion University of The Negev Research and Development Authority |
Hydrogel system comprising spatially separated bioactive polypeptides
|
|
WO2014102801A1
(en)
|
2012-12-30 |
2014-07-03 |
Hadasit Medical Research Services And Development Ltd. |
Use of alginate compositions in preventing or reducing liver damage caused by a hepatotoxic agent
|
|
KR102349183B1
(ko)
|
2013-05-08 |
2022-01-07 |
인리젠 |
단리된 신장 세포를 포함하는 오가노이드 및 이의 용도
|
|
BR112015031253B1
(pt)
|
2013-06-13 |
2021-09-28 |
Orgenesis Ltd. |
Método para produção de uma população de células transdiferenciada
|
|
EP3107549B1
(en)
|
2014-02-20 |
2020-07-01 |
B.G. Negev Technologies and Applications Ltd. |
Anionic polyplexes for use in the delivery of nucleic acids
|
|
JP6538087B2
(ja)
|
2014-05-30 |
2019-07-03 |
ザ・セカント・グループ・エルエルシー |
ポリマー材料の水媒介製造
|
|
WO2015186127A1
(en)
|
2014-06-02 |
2015-12-10 |
B. G. Negev Technologies And Applications Ltd |
Site-selective modification of polysaccharides and applications thereof
|
|
MA41296A
(fr)
|
2014-12-30 |
2017-11-07 |
Orgenesis Ltd |
Procédés de transdifférenciation et procédés d'utilisation de ceux-ci
|
|
CN109069875B
(zh)
|
2016-01-07 |
2021-12-24 |
位于本-古里安大学之内盖夫技术与应用有限公司 |
产生免疫耐受反应的组合物和方法
|
|
WO2017175229A1
(en)
|
2016-04-07 |
2017-10-12 |
B.G. Negev Technologies And Applications Ltd. |
Polysaccharide compositions and uses thereof
|
|
US20170290954A1
(en)
|
2016-04-07 |
2017-10-12 |
B. G. Negev Technologies And Applications Ltd., At Ben-Gurion University |
Compositions and methods for treating spinal cord injury
|
|
WO2018207179A1
(en)
|
2017-05-08 |
2018-11-15 |
Orgenesis Ltd. |
Transdifferentiated cell populations and methods of use thereof
|